OpenURL Connection Search

Select item for more details and to access through your institution.

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01723-7
By:
- Iannelli, Federica;
- Roca, Maria Serena;
- Lombardi, Rita;
- Ciardiello, Chiara;
- Grumetti, Laura;
- De Rienzo, Simona;
- Moccia, Tania;
- Vitagliano, Carlo;
- Sorice, Angela;
- Costantini, Susan;
- Milone, Maria Rita;
- Pucci, Biagio;
- Leone, Alessandra;
- Di Gennaro, Elena;
- Mancini, Rita;
- Ciliberto, Gennaro;
- Bruzzese, Francesca;
- Budillon, Alfredo
Publication type:
Article
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1317-6
By:
- Ciardiello, Chiara;
- Leone, Alessandra;
- Lanuti, Paola;
- Roca, Maria S.;
- Moccia, Tania;
- Minciacchi, Valentina R.;
- Minopoli, Michele;
- Gigantino, Vincenzo;
- De Cecio, Rossella;
- Rippa, Massimo;
- Petti, Lucia;
- Capone, Francesca;
- Vitagliano, Carlo;
- Milone, Maria R.;
- Pucci, Biagio;
- Lombardi, Rita;
- Iannelli, Federica;
- Di Gennaro, Elena;
- Bruzzese, Francesca;
- Marchisio, Marco
Publication type:
Article
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment.
Published in:
Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04110-w
By:
- Meo, Concetta;
- Palma, Giuseppe;
- Bruzzese, Francesca;
- Budillon, Alfredo;
- Napoli, Claudio;
- de Nigris, Filomena
Publication type:
Article
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.
Published in:
2022
By:
- Cocco, Stefania;
- Leone, Alessandra;
- Roca, Maria Serena;
- Lombardi, Rita;
- Piezzo, Michela;
- Caputo, Roberta;
- Ciardiello, Chiara;
- Costantini, Susan;
- Bruzzese, Francesca;
- Sisalli, Maria José;
- Budillon, Alfredo;
- De Laurentiis, Michelino
Publication type:
journal article
Novel pathways involved in cisplatin resistance identified by a proteomics approach in non‐small‐cell lung cancer cells.
Published in:
Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 9077, doi. 10.1002/jcp.27585
By:
- Milone, Maria Rita;
- Lombardi, Rita;
- Roca, Maria Serena;
- Bruzzese, Francesca;
- Addi, Laura;
- Pucci, Biagio;
- Budillon, Alfredo
Publication type:
Article
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.
Published in:
BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12936-w
By:
- Budillon, Alfredo;
- Leone, Alessandra;
- Passaro, Eugenia;
- Silvestro, Lucrezia;
- Foschini, Francesca;
- Iannelli, Federica;
- Roca, Maria Serena;
- Macchini, Marina;
- Bruzzese, Francesca;
- Garcia Bermejo, Maria Laura;
- Rodriguez Garrote, Mercedes;
- Tortora, Giampaolo;
- Milella, Michele;
- Reni, Michele;
- Fuchs, Claudia;
- Hewitt, Eve;
- Kubiak, Christine;
- Di Gennaro, Elena;
- Giannarelli, Diana;
- Avallone, Antonio
Publication type:
Article
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.
Published in:
Proteomics, 2011, v. 11, n. 18, p. 3725, doi. 10.1002/pmic.201100092
By:
- Bianchi, Laura;
- Bruzzese, Francesca;
- Leone, Alessandra;
- Gagliardi, Assunta;
- Puglia, Michele;
- Di Gennaro, Elena;
- Rocco, Monia;
- Gimigliano, Anna;
- Pucci, Biagio;
- Armini, Alessandro;
- Bini, Luca;
- Budillon, Alfredo
Publication type:
Article
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Published in:
Molecular Oncology, 2021, v. 15, n. 4, p. 1005, doi. 10.1002/1878-0261.12883
By:
- Lombardi, Rita;
- Sonego, Maura;
- Pucci, Biagio;
- Addi, Laura;
- Iannelli, Federica;
- Capone, Francesca;
- Alfano, Luigi;
- Roca, Maria Serena;
- Milone, Maria Rita;
- Moccia, Tania;
- Costa, Alice;
- Di Gennaro, Elena;
- Bruzzese, Francesca;
- Baldassarre, Gustavo;
- Budillon, Alfredo
Publication type:
Article
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0647-5
By:
- Terranova-Barberio, Manuela;
- Pecori, Biagio;
- Roca, Maria Serena;
- Imbimbo, Serena;
- Bruzzese, Francesca;
- Leone, Alessandra;
- Muto, Paolo;
- Delrio, Paolo;
- Avallone, Antonio;
- Budillon, Alfredo;
- Di Gennaro, Elena
Publication type:
Article
β2-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery.
Published in:
Cell Death & Disease, 2023, v. 14, n. 9, p. 1, doi. 10.1038/s41419-023-06129-9
By:
- Del Vecchio, Vitale;
- Mele, Luigi;
- Panda, Sameer Kumar;
- Sanchez-Pajares, Ibone Rubio;
- Mosca, Laura;
- Tirino, Virginia;
- Barbieri, Massimiliano;
- Bruzzese, Francesca;
- Luciano, Antonio;
- Marino, Federica Zito;
- Accardo, Marina;
- Nicoletti, Giovanni Francesco;
- Papaccio, Gianpaolo;
- Barbieri, Antonio;
- Desiderio, Vincenzo
Publication type:
Article
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Published in:
Journal of Cellular Physiology, 2011, v. 226, n. 9, p. 2378, doi. 10.1002/jcp.22574
By:
- Bruzzese, Francesca;
- Leone, Alessandra;
- Rocco, Monia;
- Carbone, Carmine;
- Piro, Geny;
- Caraglia, Michele;
- Di Gennaro, Elena;
- Budillon, Alfredo
Publication type:
Article
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells (Iressa is a trademark of the AstraZeneca group of companies.)
Published in:
Journal of Cellular Physiology, 2003, v. 195, n. 1, p. 139, doi. 10.1002/jcp.10239
By:
- Elena Di Gennaro;
- Marcella Barbarino;
- Francesca Bruzzese;
- Sonya De Lorenzo;
- Michele Caraglia;
- Alberto Abbruzzese;
- Antonio Avallone;
- Pasquale Comella;
- Francesco Caponigro;
- Stefano Pepe
Publication type:
Article
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03044-5
By:
- Filograna, Angela;
- De Tito, Stefano;
- Monte, Matteo Lo;
- Oliva, Rosario;
- Bruzzese, Francesca;
- Roca, Maria Serena;
- Zannetti, Antonella;
- Greco, Adelaide;
- Spano, Daniela;
- Ayala, Inmaculada;
- Liberti, Assunta;
- Petraccone, Luigi;
- Dathan, Nina;
- Catara, Giuliana;
- Schembri, Laura;
- Colanzi, Antonino;
- Budillon, Alfredo;
- Beccari, Andrea Rosario;
- Del Vecchio, Pompea;
- Luini, Alberto
Publication type:
Article
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Published in:
2022
By:
- Roca, Maria Serena;
- Moccia, Tania;
- Iannelli, Federica;
- Testa, Cristina;
- Vitagliano, Carlo;
- Minopoli, Michele;
- Camerlingo, Rosa;
- De Riso, Giulia;
- De Cecio, Rossella;
- Bruzzese, Francesca;
- Conte, Mariarosaria;
- Altucci, Lucia;
- Di Gennaro, Elena;
- Avallone, Antonio;
- Leone, Alessandra;
- Budillon, Alfredo
Publication type:
Correction Notice
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
By:
- Roca, Maria Serena;
- Moccia, Tania;
- Iannelli, Federica;
- Testa, Cristina;
- Vitagliano, Carlo;
- Minopoli, Michele;
- Camerlingo, Rosa;
- De Riso, Giulia;
- De Cecio, Rossella;
- Bruzzese, Francesca;
- Conte, Mariarosaria;
- Altucci, Lucia;
- Di Gennaro, Elena;
- Avallone, Antonio;
- Leone, Alessandra;
- Budillon, Alfredo
Publication type:
Article
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
By:
- Roca, Maria Serena;
- Moccia, Tania;
- Iannelli, Federica;
- Testa, Cristina;
- Vitagliano, Carlo;
- Minopoli, Michele;
- Camerlingo, Rosa;
- De Riso, Giulia;
- De Cecio, Rossella;
- Bruzzese, Francesca;
- Conte, Mariarosaria;
- Altucci, Lucia;
- Di Gennaro, Elena;
- Avallone, Antonio;
- Leone, Alessandra;
- Budillon, Alfredo
Publication type:
Article
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
By:
- Roca, Maria Serena;
- Moccia, Tania;
- Iannelli, Federica;
- Testa, Cristina;
- Vitagliano, Carlo;
- Minopoli, Michele;
- Camerlingo, Rosa;
- De Riso, Giulia;
- De Cecio, Rossella;
- Bruzzese, Francesca;
- Conte, Mariarosaria;
- Altucci, Lucia;
- Di Gennaro, Elena;
- Avallone, Antonio;
- Leone, Alessandra;
- Budillon, Alfredo
Publication type:
Article
Combination of Spirulina platensis , Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?
Published in:
Journal of Cardiovascular Development & Disease (JCDD), 2022, v. 9, n. 12, p. 423, doi. 10.3390/jcdd9120423
By:
- Quagliariello, Vincenzo;
- Basilicata, Manuela Giovanna;
- Pepe, Giacomo;
- De Anseris, Raffaele;
- Di Mauro, Annabella;
- Scognamiglio, Giosuè;
- Palma, Giuseppe;
- Vestuto, Vincenzo;
- Buccolo, Simona;
- Luciano, Antonio;
- Barbieri, Massimiliano;
- Bruzzese, Francesca;
- Maurea, Carlo;
- Pumpo, Rossella;
- Ostacolo, Carmine;
- Campiglia, Pietro;
- Berretta, Massimiliano;
- Maurea, Nicola
Publication type:
Article
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies.
Published in:
Nutrients, 2023, v. 15, n. 3, p. 563, doi. 10.3390/nu15030563
By:
- Tacconi, Edoardo;
- Palma, Giuseppe;
- De Biase, Davide;
- Luciano, Antonio;
- Barbieri, Massimiliano;
- de Nigris, Filomena;
- Bruzzese, Francesca
Publication type:
Article

Found: 19

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.

Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment.

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.

Novel pathways involved in cisplatin resistance identified by a proteomics approach in non‐small‐cell lung cancer cells.

Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.

Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.

β<sub>2</sub>-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery.

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

Critical role of both p27<sup>KIP1</sup>and p21<sup>CIP1/WAF1</sup> in the antiproliferative effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells (Iressa is a trademark of the AstraZeneca group of companies.)

Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.

Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

Combination of Spirulina platensis , Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?

Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies.